Why TENS Machine Manufactury for Medical Device Brands Is Growing Across Global Clinics

DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- Globally, the medical industry is undergoing a major ...

Doctors warn against common over-the-counter allergy medicine taken by tens of millions

Citing risks of 'substantial' brain damage, physicians are calling for a ban on a popular over-the-counter allergy medicine, ...

UPMC Passavant adds $10M cancer treatment technology

UPMC Passavant is expanding its cancer treatment capabilities with a $10 million linear accelerator that can deliver more ...
The Chosun Ilbo on MSN

US investors call South Korea’s Coupang response Venezuela-style

U.S. investment firms GreenOak and Altimeter, in a Notice of Intent submitted to the South Korean government on the 22nd ...

National childhood type 1 diabetes screening could prevent thousands of emergency diagnoses, UK study shows

A landmark UK study involving tens of thousands of families has shown that childhood screening for type 1 diabetes is ...
Cornwall Live

Dad's desperate fight for life saving treatment for baby with just days to live

Adam is fighting against the clock for tiny Maverick's transfer to the UK and survival. 'All we wanted was a chance to save ...

Ron DeSantis will have 'blood on his hands' if HIV funding isn't restored, Democratic chair says

Over 10,000 Floridians are losing HIV medication due to a supposed shortfall in the state budget. Democratic Party Chair ...

Dr Ümit Şentürk Explains Why the Best Hair Transplant Clinics Focus on Medicine, Not Marketing

Health tourism—the practice of travelling across borders for medical care—is one of the fastest-growing segments of the ...

Pine bark removes pharmaceutical residues from wastewater—an affordable way to keep antibiotics out of nature

Researchers at the University of Oulu, Finland, have developed a pine-bark–based water-treatment medium that efficiently removes antibiotics as well as residues of blood-pressure and antidepressant ...

INO-3107 At The Crossroads: FDA Review Drives Inovio's Upside And Risk

Inovio Pharmaceuticals faces an October 30 PDUFA date for INO-3107 with high regulatory risk and only a 5-7 month cash runway. Read why INO stock is a hold.
News-Medical.Net on MSN

Landmark UK study supports nationwide screening for childhood type 1 diabetes

A landmark UK study involving tens of thousands of families has shown that childhood screening for type 1 diabetes is ...

Chronic pelvic pain and endometriosis affect thousands in NZ—a new study reveals the staggering cost

For tens of thousands of New Zealanders, endometriosis and chronic pelvic pain are lived quietly—through canceled plans, lost jobs and years of being told their pain is "normal." ...